Linda Eissenberg

Assistant Professor of Medicine

    • 1092 Citations
    1981 …2019

    Research output per year

    If you made any changes in Pure these will be visible here soon.

    Fingerprint Dive into the research topics where Linda Eissenberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 21 Similar Profiles

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells

    Karpova, D., Rettig, M. P., Ritchey, J., Cancilla, D., Christ, S., Gehrs, L., Chendamarai, E., Evbuomwan, M. O., Holt, M., Zhang, J., Abou-Ezzi, G., Celik, H., Wiercinska, E., Yang, W., Gao, F., Eissenberg, L. G., Heier, R. F., Arnett, S. D., Meyers, M. J., Prinsen, M. J. & 7 others, Griggs, D. W., Trumpp, A., Ruminski, P. G., Morrow, D. M., Bonig, H. B., Link, D. C. & DiPersio, J. F., 2019, In : Journal of Clinical Investigation. 129, 7, p. 2745-2759 15 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations

    An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

    Cooper, M. L., Choi, J., Staser, K., Ritchey, J. K., Devenport, J. M., Eckardt, K., Rettig, M., Wang, B., Eissenberg, L., Ghobadi, A., Gehrs, L. N., Prior, J. L., Achilefu, S., Miller, C., Fronick, C. C., O’Neal, J., Gao, F., Weinstock, D. M., Gutierrez, A., Fulton, R. & 1 others, Dipersio, J., Sep 1 2018, In : Leukemia. 32, 9, p. 1970-1983 14 p.

    Research output: Contribution to journalArticle

  • 72 Scopus citations

    Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice

    Ghobadi, A., Rettig, M. P., Holt, M. S., Ritchey, J. K., Kennerly, K., Chendamarai, E., Eissenberg, L. & DiPersio, J. F., Jun 7 2018, In : Blood. 131, 23, p. 2594-2596 3 p.

    Research output: Contribution to journalLetter

    2 Scopus citations

    Preclinical development of a bispecific antibody that safely and effectively targets CD19 and CD47 for the treatment of B-cell lymphoma and leukemia

    Buatois, V., Johnson, Z., Salgado-Pires, S., Papaioannou, A., Hatterer, E., Chauchet, X., Richard, F., Barba, L., Daubeuf, B., Cons, L., Broyer, L., D'Asaro, M., Matthes, T., LeGallou, S., Fest, T., Tarte, K., Clarke Hinojosa, R. K., Ferrer, E. G., Ribera, J. M., Dey, A. & 11 others, Bailey, K., Fielding, A. K., Eissenberg, L., Ritchey, J., Rettig, M., DiPersio, J. F., Kosco-Vilbois, M. H., Masternak, K., Fischer, N., Shang, L. & Ferlin, W. G., Aug 2018, In : Molecular Cancer Therapeutics. 17, 8, p. 1739-1751 13 p.

    Research output: Contribution to journalArticle

  • 21 Scopus citations

    Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition

    Kim, A. G., Vrecenak, J. D., Boelig, M. M., Eissenberg, L., Rettig, M. P., Riley, J. S., Holt, M. S., Conner, M. A., Loukogeorgakis, S. P., Li, H., DiPersio, J. F., Flake, A. W. & Peranteau, W. H., Nov 17 2016, In : Blood. 128, 20, p. 2457-2461 5 p.

    Research output: Contribution to journalArticle

    Open Access
  • 16 Scopus citations